Hodgkin's disease in Turkish children: Clinical characteristics and treatment results of 210 patients

Pediatric Hematology and Oncology

Volumn 16, Issue 2, 1999, Pages 119-129

  Büyükpamukçu, Münevver ^a   Atahan, Lale ^a   Çaǧlar, Melda ^a   Kutluk, Tezer ^a   Akyüz, Canan ^a   Hazar, Volkan ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Children; Epidemiology; Hodgkin's disease; Treatment

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CELL SURVIVAL; CHILD; DEVELOPING COUNTRY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; TURKEY (REPUBLIC);

EID: 0344026113     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277443     Document Type: Article

References (41)

1. Gutensohn N, Cole P. Chilhood social environment and Hodgkin's disease. N Engl J Med. 1981;304: 5-40.
2. Gad El-Mawla N, El-Deeb BB, Abu-Gabal A, et al. Pediatric Hodgkin's disease in Egypt. Cancer. 1983;52:1129-1131.
3. Medeiros LJ, Greiner TC. Hodgkin's disease. Cancer. 1995;75:357-369.
4. Kolygin BA. Hodgkin's disease in children: a retrospective study of the 20-year experience (1968-1987) at a single institute. Med Pediatr Oncol. 1995;25:407-413.
5. Jacobs P, King HS, Karabus C, et al. Hodgkin's disease in children: a ten-year experience in South Africa. Cancer. 1984;53:210-213.
6. Faria SL, Vassallo J, Cosset JM, Bradalise SR. Childhood Hodgkin's disease in Compinas, Brazil. Med Pediatr Oncol. 1996;26:90-94.
7. Oberlin O, Leverger G, Pacqument H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol. 1992;10:1602-1608.
8. Vecchi V, Burnelli R, Fabio S, et al. Childhood Hodgkin's disease: results of the Italian multicentric study AIEOP-MH'89-CNR. Third International Symposium on Hodgkin's Lymphoma, 18-23 September 1995, Köln, Germany, p 191 (abstr).
9. Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol. 1987;5:742-749.
10. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford Experience. J Clin Oncol. 1994;12:2160-2166.
11. Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol. 1993;11:100-108.
12. Donaldson SS, Whitaker SJ, Plowmann PN, et al. Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol. 1990;8:1128-1137.
13. Carbone PP, Kaplan HS, Musskoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
14. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966;26:1063-1081.
15. DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970;73:891-895.
16. Kaplan ES, Meier P. Non-parametric estimation from incomplete observations. Am Stat Assoc J. 1958;53A:457-480.
17. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation for each patient, II: analysis and examples. Br J Cancer. 1977;35:1-39.
18. Hiçsönmez G, Büyükpamukçu M. Pediatric hematology and oncology in Turkey. Ph/o Forum. 1994;1: 4-8.
19. Correa P, O'Conor GT. Epidemiologic pattern of Hodgkin's disease. Int J Cancer. 1971;8:192-201.
20. Cleary SF, Link MP, Donaldson SS. Hodgkin's disease in the very young. Int J Radial Oncol Biol Phys. 1993;28:77-83.
21. Parkes SE, Coad NAG, Muir KR, et al. Hodgkin's disease in children in the West Midlands, 1957-1986: a large population-based study. Pediatr Hematol Oncol. 1994;11:471-486.
22. Çavdar AO, Yavuz G, Babacan E, et al. Burkitt's lymphoma in Turkish children: clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994;14:323-330.
23. Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol. 1987;129:86-91.
24. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet. 1991;337:320-322.
25. Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol. 1991;44:844-848.
26. Weiss LM, Chen Y Y, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative insitu hybridization and polymerase chain reaction study. Am J Pathol. 1991;139:1259-1265.
27. Pamir A, Çavdar AO, Vontanthen R, et al. Epstein-Barr virus latent membrane protein expression and distribution of viral subtypes in Turkish Hodgkin's disease: a comparative study with non-neoplastic lymphoid hyperplasia. Med Pediatr Oncol. 1995;25:260 (abstr).
28. Çevik N, Büyükpamukçu M, Sarialioglu F, et al. Experience in the management of childhood Hodgkin's disease. Proceedings of the 15th International Congress of Chemotherapy, Istanbul, Turkey, 19-24 July 1987, p 648-650.
29. Matawy MS, Omar YT. Hodgkin's disease in children in Kuwait. Cancer. 1986;57:2255-2259.
30. Dinshaw KA, Panda S, Advani S, et al. Pediatric Hodgkin's disease in India. J Clin Oncol. 1985;3:1605-1612.
31. Shankar AG, Ashley S, Radford M, Barrett A, Wright D, Pinkerton CR. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol. 1997;15:2622-2630.
32. Weinshel EL, Peterson BA. Hodgkin's disease. CA Cancer J Clin. 1993;43:327-346.
33. Mockonko K, Fejes M, Breazavscak DM, et al. The relation between EBV antibodies clinical symptomatology and immune deficiency in patients with Hodgkin's disease. Cancer. 1979;44:2065-2070.
34. Tekinalp G, Çevik N, Büyükpamukçu M. Hodgkin lenfomali vakalarda serum ve doku çinko düzeyleri. Çocuk Sagligi ve Hastaliklari Dergisi. 1985;28:275-281.
35. Çavdar AO, Babacan E, Gözdasoglu S, et al. Zinc and anergy in pediatric Hodgkin's disease in Türkiye. Cancer. 1987;59:305-309.
36. Herman TS, Hoppe RT, Donaldson SS, et al. Late relapse among patients treated for Hodgkin's disease. Ann Intern Med. 1985;102:292-297.
37. Ilhan I, Sarialioglu F, Özbarlas N, et al. Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy. Postgrad Med J. 1995;71:164-167.
38. Ilhan I, Sarialioglu F, Bilgiç H, et al. Long-term pulmonary function in children with Hodgkin's disease. Acta Pediatr. 1996;85:324-326.
39. Wiliams J, Thompson E, Smith KL. Long-term results of treatment of children and adolescents with Hodgkin's disease. Cancer. 1980;46:2123-2125.
40. Kaldor JM, Day NE, Clarke A, et al. Leukemia following Hodgkin's disease. N Eng J Med. 1990;322: 7-13.
41. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-751.